|
|
|
Press Release: Seventh Asia Pac Pharma and Medical Device Compliance Congress Agenda and Brochure Now Available
|
- Sponsored by Asia Pacific Healthcare Industry Compliance Team
- Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
- September 13 - 15, 2017
- InterContinental Shanghai, Shanghai, China
- www.AsianPharmaCongress.com
PRESS RELEASE
Phone: 800-503-6498
Email: registration@hcconferences.com
Website: www.AsianPharmaCongress.com
|
EARLY BIRD REGISTRATION
- SAVE UP TO $600 -
|
Register by Friday, July 28, 2017
and save up to $600.
Click here to register.
|
|
|
SHANGHAI, CHINA -- PHARMA UPDATE NEWS SERVICE™ -- JULY 11, 2017: The Seventh Asia Pacific Pharmaceutical and Medical Device Compliance Congress, www.AsianPharmaCongress.com, will be held September 13 - 15, 2017 at the InterContinental Shanghai in Shanghai, China.
|
|
KEYNOTE SPEAKERS
|
Mike Dethick, LLB
Managing Director, R&D-Based Pharmaceutical Association Committee, Beijing, China |
Luca Genovese, AMID
Researcher, Access to Medicine Foundation, Amsterdam, Netherlands |
Hervé Gisserot
Senior Vice President and Head of Pharmaceuticals Asia Pacific, GlaxoSmithKline, Former Senior Vice President and General Manager of Pharmaceuticals and Vaccines, GlaxoSmithKline (China), Former President, Leem, Singapore
|
Kent Kedl, MA
Senior Partner, Control Risks, Former Vice President and General Manager, Technomic Asia, Shanghai, China |
George “Ren” McEachern, CFE, CAMS
Supervisory Special Agent, International Corruption Squad, US Federal Bureau of Investigation, Washington, DC, USA |
Jean-Christophe Pointeau, PhD
Country Chair, Sanofi China, Board Member, JHL Biotech, Former President, China, Bristol-Myers Squibb, Shanghai, China
|
Christopher L. White, JD
Chief Operating Officer General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA |
Professor Huang Yong
Competition Law Center, University of International Business and Economics, Executive Vice Chair, Expert Consultation Group, Anti-Monopoly Committee, State Council, Peoples Republic of China, Beijing, China
|
|
|
CO-CHAIRS
|
Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore |
Maija Burtmanis, LLB/BSc LLM
Regional Compliance Director, Japan / Asia Pacific, Shire, Former Healthcare CO, Asia Pacific Medical Sciences, Johnson & Johnson, Singapore |
Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore
|
Maria “Maru” Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China |
Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics, Former Compliance Director, Asia, Abbott Laboratories (Singapore) Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore
|
|
|
FEATURING A PRECONFERENCE
|
- Training in Compliance and Ethics Basics
|
|
PLENARY SESSIONS
|
- Keynote: Hervé Gisserot, SVP and Head of Pharmaceuticals, Asia Pacific, GSK
- Keynote: Jean-Christophe Pointeau, PhD, Country Chair, Sanofi China
- Keynote: Prof Huang Yong, Competition Law Center, Univ of Int’l Business and Economics
- Keynote: George “Ren” McEachern, CFE, CAMS, Supervisory Special Agent, FBI
- Global Chief Compliance Officer Roundtable
- Managing Pharma & Device Risk Across the Asia Pacific Region
- Asia Pac Anticorruption Update Roundtable
- Asia Pac Public-Private Pharmaceutical Partnerships
- The Chinese Anti-unfair Competition Law
- RDPAC Pharmaceutical Enterprise Ethical Business Practice
- AdvaMed’S Code of Ethics on Interactions with HCPs in China
- The Continued Evolution of Compliance as a Profession
- Pharmaceutical Compliance and Access to Medicine
- Roundtable on New Directions in Compliance Innovation
|
|
|
|
AND MINI SUMMITS
|
- Chinese Anticorruption and Compliance Best Practices Roundtable
- Asia Pac Medical Device Compliance Regulatory Developments and Burning Issues
- Separation and Collaboration between Medical Education and Product Promotion
- Organizational Justice: One of the Pillars of a Culture of Integrity
- Transparency Reporting to Prevent Corruption Risk
- How to Eliminate Anti-Corruption Risks for Tier 2 and Tier 3 Cities and Mobile Offices
- Korean Anticorruption and Compliance Best Practices Roundtable
- Global Data Privacy Update and the Impact to the Life Sciences Industry
- The Art of the Investigation: Planning, Executing and Completing Investigations
- The Evolution of Compliance Organizations
- Third Party Management, including Due Diligence, Contracting, Monitoring and Payment
- When will you Deploy Robot(s) in your Compliance Team?
- Compliance and Ethical Issues in Patient Support Programs and Patient Advocacy Organizations
- Fraud Trends in Asia Pacific and How Companies are Dealing with Them
|
|
|
FEATURED FACULTY
|
Ted Acosta, Esq.
Americas Vice Chair, Risk Management, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France |
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Executive Committee, Pharmaceutical Compliance Forum, Former VP and CCO, Dendreon, Former Associate GC and ED of Compliance, Seattle Genetics, Chicago, IL, USA |
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA
|
M. Jason Brooke, JD
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance, and Investigations, Navigant, Former Board Member and General Counsel, Vasoptic Medical, Inc., Washington, DC |
Brian Caster, JD
Regional Compliance Investigations Lead, Pfizer, Tokyo, Japan |
Eric Carlson, JD
Partner, Covington & Burling LLP, Shanghai, China
|
Stacy Chai
Partner, Fraud Investigation & Dispute Services, EY, Singapore |
Praween Chantanakomes, JD
Associate, Baker & McKenzie, Bangkok, Thailand |
Chi Chen
Fraud Investigation & Dispute Services, EY, Shanghai, China
|
Vivian Chen, LLB
Head of Compliance, Alcon Laboratories China, A Novartis Division, Former Head of Ethic and Compliance, Greater China, Baxter Intl Inc., Beijing, China |
Steven Chon, MA
Director, Fraud Investigation & Dispute Services (Hong Kong & Korea), EY, Hong Kong |
Hwa Soo Chung, JD, MPA
Chair, Health Practice Group, Kim and Chang, Seoul, South Korea
|
Campbell Clark, LLB, MJ
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore |
Karen Eryou
Head, Ethics AND Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium |
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division, Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore
|
J. Mark Farrar, CPA, CFE, CFF
Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant, Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA |
Chris Fordham
Managing Partner, Asia Pacific Area, Fraud Investigation, and Dispute Services, EY, Hong Kong |
Ewa Holker
Legal & Compliance Director (APAC), Ferring Pharmaceuticals, Former Director, Legal & Compliance, Asia Pacific, Zimmer Biomet, Singapore
|
Vanessa Han Jun
Head of Compliance, China, Novo Nordisk, Shanghai, China |
Christine Hu, LLM
Legal and Compliance Director, Medtronic Kanghui Orthopedics, Former Legal, Compliance & Government Affair Director, Zimmer, Beijing, China |
Yota Kikuchi
Director, Compliance Rules & Management, Japan Pharma Business Unit, Takeda Pharmaceuticals, Member, Code Compliance Committee, Japan Pharmaceutical Manufacturers Association, Member, IFPMA Ethics & Business Integrity Committee (eBIC), Tokyo, Japan
|
Sarah Kochling
Managing Principal, Blossom Innovation, Board of Directors, American Chamber of Commerce, Shanghai, Shanghai, China |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA |
Patrik Kronig
Head of Compliance Pharma Asia Pacific, Roche, Singapore
|
David Kurlander, MBA
Vice President, Health Care Compliance, Privacy, FCPA, Ortho Clinical Diagnostics, Former Finance Director, Tax and Commercial Compliance, Ethicon, A Johnson and Johnson Company, New York, NY, USA |
Rachel B. Layburn, MBA
Partner in Charge, Forensic and Investigations Practice, KPMG China, Beijing, China |
Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China
|
Howard Lin
Vice President, Ethics & Compliance - Lilly China, Eli Lilly and Company, Hong Kong |
Michael K. Loucks, JD
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA |
Albert van Maaren, MSc
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore
|
Angela Main, MA
Vice President, Global Chief Compliance Officer and Associate General Counsel, Asia Pacific , Zimmer Biomet, Former Senior Legal Counsel, Covidien Pte Ltd, Singapore |
Christine Ng
Compliance Officer, China, GSK, Shanghai, China |
Jennie Orrico, JD
Senior Vice President, Chief Compliance and Risk Officer, Shire, Vice President and Associate General Counsel, Compliance, Baxalta Incorporated, Chicago, IL, USA
|
Katrina Reinhardt, JD
Regional Head Ethics and Compliance, Asia Pacific, Baxter Healthcare, Former Governance and Compliance Director, Greater China, Dow Corning, Singapore |
Redentor Romero, JD
Associate Director, Global Third Party Compliance Program, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel, AstraZeneca, Singapore |
Sandeep Seth, LLB
Director, Corporate Compliance, Pfizer India, Former Director, Compliance, India, Sri Lanka, Bangladesh, Pakistan and Nepal, MSD Pharmaceuticals, Mumbai, India
|
Clarissa Shen
Country Compliance Officer, Sanofi China, Former Associate Compliance, Director, Eli Lilly China, Shanghai, China |
Sabina Sudan, LLB, LLM
ECLS-Consults (Ethics/Compliance/Legal/ Sustainability), Legal/International Compliance and Risk Management Professional, Former Vice President and Compliance Officer, Pharma, EJEMAP, GSK, Former Director, Compliance, APAC, Abbott Labs, Singapore and Delhi, India |
John Tan, JD
Partner, ReedSmith, Former China Regional Compliance Director, Pfizer, Shanghai, China
|
Yuet Ming Tham, JD
Partner, Sidley Austin LLP, Former Asia Pacific Regional Compliance Director, Pfizer, Former Deputy Public Prosecutor, Singapore, Hong Kong |
John Tsai
Forensic Partner, Fraud Investigation & Dispute Services, EY, Shanghai, China |
Jonathan Shun Wah, PCLL
Senior Director, China Investigations Team Lead, Pfizer, Hong Kong
|
YanXiang (Michael) Wang, MBA
Country Director, China, PATH, Former Commercial Development Director, China, Becton Dickinson, Former Area Sales Manager, China, Boehringer Ingelheim, Former Area Assistant Manager, China, GlaxoSmithKline, Beijing, China |
Chae Sing Wong
Former Head of Regional Compliance (APAC, MEA, LATM), Mundipharma Pte Ltd, Former Compliance Director, Asia, ANZ and Japan, Baxalta, Former Compliance Director Asia Area, AstraZeneca, Singapore |
Joyce Wong
Managing Director, Polaris Asia-Pacific, Former General Manager, Eli Lilly Asia Inc., Hong Kong
|
Carol Wu
Third Party Audit, Asia, Global Ethics & Compliance, GSK, Former Manager, Ethics & Compliance- China, Hospira, Former Senior Compliance Manager, AstraZeneca, Shanghai, China |
Pete (Lijun) Wu, MS, MBA
Chief Compliance Officer, Novartis (Group) China, Shanghai, China |
Vivian Wu, LLB, LLM
Counsel, Fenxun Partners, Former Partner, Baker McKenzie, Beijing, China
|
Vivian Xing, LLB, LLM
Regional Counsel, Danaher Diagnostics Platform, Former Assistant General Counsel, Greater China, Beckman Coulter, Former Regional Counsel Asia Pacific, Eastman Chemical Company, Shanghai, China |
Chen Yang, LLB, LLM
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China |
Henry Yao, MA
Head of Compliance, Roche Diagnostics, Asia Compliance Leader, GE Energy Management, Shanghai, China
|
Xi Zhang, LLM, PhD Law
Vice President & General Counsel Greater China, Bayer (China) Limited, Former General Counsel Asia, Celanese, Shanghai, China |
Mike Zhao, MBA
Ethics and Compliance Lead, China, UCB, Former Compliance Manager, Johnson & Johnson, Shanghai, China
|
|
|
2017-2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
ELEVENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 15 - 17, 2017
Lisbon Marriott Hotel
Lisbon, Portugal
www.International PharmaCongress.com
|
|
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 13 - 15, 2017
InterContinental Shanghai, Shanghai, China
www.Asian PharmaCongress.com
|
|
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 - 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Spring 2018
Mumbai, India
Coming Soon
|
|
|
|
|
|
SIMULTANEOUS CHINESE / ENGLISH TRANSLATION OFFERED
|
And the Following Sessions Offered in Chinese:
- Chinese Anticorruption and Compliance Best Practices Roundtable
- How to Eliminate Anti-Corruption Risks for Tier 2 and Tier 3 Cities and Mobile Offices
|
|
SPONSORED BY:
|
|
The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.
|
|
COSPONSORED BY:
|
The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 70 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
BRONZE
|
|
|
MEDIA PARTNER:
|
|
|
CONTINUING EDUCATION CREDITS:
|
Accounting Professionals: Approved for up to 19.0 NASBA CPE credits.
Compliance Professionals: Pending approval for Compliance Certification Board CCB credits.
Attorneys: Pending approval for Pennsylvania MCLE credits.
Click here for more information.
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
|
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE ETHICS AND COMPLIANCE CONGRESS PLANNING COMMITTEE
|
|
CO-CHAIRS
|
|
Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore
Maija Burtmanis, LLB/BSc LLM
Regional Compliance Director, Japan/Asia Pacific, Shire, Former Healthcare CO, Asia Pacific, Medical Sciences, Johnson & Johnson, Former Associate GC, Alcon Russia, Former Asia Pacific, Country CO, Novartis SG, Singapore
Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore
Maria “Maru” Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics, Former Compliance Director, Asia, Abbott Laboratories Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore
|
|
MEMBERS
|
|
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Executive Committee, Pharmaceutical Compliance Forum, Former VP and CCO, Dendreon, Former Associate GC and ED of Compliance, Seattle Genetics, Chicago, IL, USA
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA
Tom Chan, JD, LLM
Head of Legal, Greater China, Takeda (China) Holdings Co., LTD, Shanghai, China
Campbell Clark
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Singapore
Abigail Enriquez
Assistant Business Development Manage, Baker & McKenzie, Manilla, Philippines
Karen Eryou
Head, Ethics and Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium
Michael B. Dusseau
Vice President, Compliance Operations, Allergan plc, Divisional Compliance Officer, Merck, Former Compliance Officer, Schering-Plough, Parsippany, NJ
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division, Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore
Ewa Holker
Legal & Compliance Director (APAC), Ferring Pharmaceuticals, Former Director, Legal & Compliance, Asia Pacific, Zimmer Biomet, Singapore
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
Patrik Kronig
Head of Compliance Pharma Asia Pacific, Roche, Singapore
Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China
Howard Lin
Vice President, Ethics & Compliance – Lilly China, Eli Lilly and Company, Hong Kong
Chris Royal
Vice President, Ethics and Compliance Officer Asia Pacific, China and Japan, GSK, Shanghai, China
Sabina Sudan, LLB, LLM
Legal/International Compliance and Risk Management Professional (Singapore / New Delhi, India), Former Vice President and Compliance Officer, Pharma, EJEMAP, GSK, Former Director, Compliance, APAC, Abbott Labs, Delhi, India
Albert van Maaren, MSc
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore
Katrina Reinhardt, JD
Regional Head Ethics and Compliance, Asia Pacific, Baxter Healthcare, Former Governance and Compliance Director, Greater China, Dow Corning, Singapore
Carol Shi
Compliance Director, Asia Area and ANZ, AstraZeneca, Singapore
Emmanuel Vignal
Partner and Greater China Leader, Fraud Investigation & Dispute Services, EY, Shanghai, China
Jonathan Shun Wah, PCLL
Senior Director, China Investigations Team Lead, Pfizer, Hong Kong
Chae Sing Wong
Former Head of Regional Compliance (APAC, MEA, LATM), Mundipharma Pte Ltd, Former Compliance Director, Asia, ANZ and Japan, Baxalta, Former Compliance Director Asia Area, AstraZeneca, Singapore
Hideki Yamanaka
Head of Ethics and Compliance, Japan and Vice President, Astellas Pharma, Tokyo, Japan
Xi Zhang, LLM, PhD Law
Vice President & General Counsel Greater China, Bayer (China) Limited, Former General Counsel Asia, Celanese, Shanghai, China
|
|
ASIA PACIFIC PHARMA CONGRESS IS
|
|
|
ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
2007 – Brussels
2008 – Paris
2009 – Rome
2010 – Berlin
2011 – Istanbul
2011 – Singapore
2012 – Budapest
2012 – Shanghai
2012 – São Paulo
2013 – Madrid
2013 – Kuala Lumpur
2014 – Dubai
2014 – Mexico City
2014 – Shanghai
2015 - Manila
2016 – Warsaw
2017 – Lisbon
|
|
|
|
|
|
|
|
|
